Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2024

Feb 26, 2024

30291_dirs_2024-02-26_5caf84aa-ece8-4ec1-b54f-b90eced66042.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2024-02-22

Reporting Person: Singhal Priya (Head of Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-22 Common Stock S 262 $221.23 Disposed 4886.0915 Direct